Abstract
We aimed to investigate the efficacy of two different doses of doxazosin, 4 and 8 mg, in medical expulsive therapy (MET). This prospective randomized study included a total of 66 patients with distal ureteral stones which were radio-opaque and ≤10 mm. All patients were randomly divided into three groups: Group 1 included 25 patients receiving 4 mg doxazosin. Group 2 included 22 patients receiving 8 mg doxazosin. Diclofenac 100 mg p.o. and daily 1500–2000 cc hydration were advised to the patients in Groups 1 and 2 to relieve pain. Group 3 consisted of 19 patients who were defined as control group and received only hydration and analgesics. The mean age of the patients was 30 ± 7.6, 37.9 ± 11.5 and 33 ± 11.3 in Group 1, Group 2 and Group 3, respectively. The mean stone size was 6.6 ± 1.4, 7.1 ± 1.5 and 6.6 ± 1.5 in Group 1, Group 2 and Group 3, respectively. The stone expulsion rate of the patient groups was 18/25 (72 %), 15/22 (68.1 %) and 5/19 (25.3 %). There were significantly fewer pain episodes and lower analgesic requirement in Groups 1 and 2 (p = 0.021). However, the difference between Group 1 and Group 2 was non-significant (p = 0.207). Given the data of the present study, doxazosin, an alpha receptor blocker, exhibited equal efficacy with 4 or 8 mg doses in MET and was used safely and efficiently in ureteral stones <10 mm. The findings of the present study showed that 4 mg dose is effective, when doxazosin is preferred for MET.
Similar content being viewed by others
References
Hollingsworth JM, Norton EC, Kaufman SR et al (2013) Medical expulsive therapy versus early endoscopic stone removal for acute renal colic: an instrumental variable analysis. J Urol 190:882–887
Preminger GM, Tiselius HG, Assimos DG et al (2007) EAU/AUA nephrolithiasis guideline panel. Guidelines on urolithiasis. J Urol 178(6):2418–2434
Preminger GM, Tiselius HG, Assimos DG et al (2007) American Urological Association Education and Research, Inc; European Association of Urology. 2007 Guideline for the management of ureteral calculi. Eur Urol 52(6):1610–1631
Preminger GM, Tiselius HG, Assimos DG et al (2007) Guideline for the management ureteral calculi. J Urol 178:2418–2434
Malin JM Jr, Deane RF, Boyarsky S (1970) Characterisation of adrenergic receptors in human ureter. Br J Urol 42:171–174
Salehi M, Fouladi MM, Shiery H et al (2005) Does methylprednisolone acetate increase the success rate of medical therapy for passing distal üreteral stones? Eur Urol Suppl 4(3):25
Porpiglia F, Destefanis P, Fioric C et al (2000) Effectiveness of nifedipine and deflazacort in management of distal ureter Stones. Urology 56:579–582
Itoh Y, Kojima Y, Yasui T et al (2007) Examination of alpha 1 adrenoceptor subtypes in the human ureter. Int J Urol 14:749–753
Laird JM, Roza C, Cervero F (1997) Effects of artificial calculosis on rat ureter motility: peripheral contribution to the pain of ureteric colic. Am J Physiol 272:R1409–R1416
Maggi CA, Giuliani S (1995) A pharmacological analysis of calcium channels involved in phasic and tonic responses of the guinea-pig ureter to high potassium. J Auton Pharmacol 15:55–64
Kumar S, Kurdia KC, Ganesamoni R et al (2013) Randomized controlled trial to comparing the efficacy of naftopidil and tamsulosin as medical expulsive therapy in combination with prednisolone for distal ureteral Stones. Korean J Urol 54(5):311–315
Yılmaz E, Batislam E, Basar MM et al (2005) The comparison and efficacy of 3 different alpha1-adrenergic blockers for distal ureteral stones. J Urol 176(6):2010–2012
Pickard R, Starr K, MacLennan G et al (2015) Medical expulsive therapy in adults with ureteric colic: a multicentre, randomised, placebo-controlled trial. Lancet 25 386(9991):341–349
Furyk JS, Chu K, Banks C et al (2016) Distal ureteric stones and tamsulosin: a double-blind, placebo-controlled, randomized, multicenter trial. Ann Emerg Med 67(1):86–95
Zehri AA, Ather MH, Abbas F et al (2010) Preliminary study of efficacy of doxazosin as a medical expulsive therapy of distal ureteric Stones in a randomized clinical trial. Urology 75(6):1285–1288
Erturhan S, Bayrak O, Sarıca K et al (2013) Efficacy of medical expulsive treatment with doxazosin in pediatric patients. Urology 81(3):640–643
Aydogdu O, Burgu B, Gucuk A et al (2009) Effectiveness of doxazosin in treatment of distal ureter Stones in children. J Urol 182(6):2880–2884
Miller OF, Kane CJ (1999) Time to stone passage for observed ureteral calculi: a guide for patient education. J Urol 162:688–690
Acknowledgments
Thanks to Elzem Sen for final language revision.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
All the authors declare that they have no conflict of interest.
Ethical standards
All studies have been approved by the appropriate ethics committee and have, therefore, been performed in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments. All persons gave their informed consent prior to their inclusion in the study. This article does not contain any studies with human participants or animals performed by any of the authors.
Rights and permissions
About this article
Cite this article
Sen, H., Erturhan, S., Sadioglu, E. et al. A comparison of efficacy of doxazosin 4 and 8 mg in medical expulsive therapy of distal ureteral stones: a prospective randomized clinical trial. Urolithiasis 45, 461–464 (2017). https://doi.org/10.1007/s00240-016-0927-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00240-016-0927-0